News dal mondo
16
Lug
EU DG SANTE and EMA sign Working Arrangement with New Zealand Ministry of Health
DG SANTE and the European Medicines Agency (EMA) have signed a Working Arrangement with New Zealand Ministry of Health (incorporating the New Zealand Medicines and Medical Devices Safety Authority - Medsafe) this week, to strengthen collaboration and exchange of information on medicinal products. The agreement was signed by DG SANTE Director-General Sandra Gallina and EMA Executive Director Emer Cooke. Director-General Audrey Sonerson signed for the New Zealand Ministry of Health. The purpose of this Working Arrangement is to strengthen cooperation between signatories across a range of areas in public health, while promoting the timely, secure exchange of information. Deliverables from the Arrangement will include: The Arrangement will run from 6 July 2026 [European Commission]
03
Ago
Destiniamo parte dei fondi per la difesa alla produzione di farmaci fuori brevetto
Le “montagne russe” provocate dalla violenta ma ondivaga politica sui dazi di Trump e sui...
31
Lug
FDA unveils FY 2027 user fee rates
The US Food and Drug Administration (FDA) has published its user fee rates for FY 2027 across its prescription...
29
Lug
Esenzione sui dazi per taluni prodotti provenienti dagli USA
Il 25 giugno 2026 è stato pubblicato il REGOLAMENTO (UE) 2026/1455 DEL PARLAMENTO EUROPEO E DEL...
17
Lug
Inside Pharma’s Push for More Resilient Supply Chains
Industry leaders from Samsung Biologics and Fujifilm Biotechnologies discuss how regional manufacturing,...
le ultime news
03 Ago
Destiniamo parte dei fondi per la difesa alla produzione di farmaci fuori brevetto
31 Lug
FDA unveils FY 2027 user fee rates
29 Lug
Esenzione sui dazi per taluni prodotti provenienti dagli USA
17 Lug
Inside Pharma’s Push for More Resilient Supply Chains
17 Lug
US FDA CDER plans new guidance on AI, electronic safety report submissions, and more
16 Lug
EU DG SANTE and EMA sign Working Arrangement with New Zealand Ministry of Health
15 Lug
Riforma farmaceutica. Via libera della Commissione Sanità del Senato
14 Lug
China NMPA conducts management review of QMS for regulation of vaccine and drug GMP compliance